Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "University"

750 News Found

Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
Public Health | April 25, 2026

Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement

The summit brought together over 150 doctors, researchers, and practitioners worldwide


IMCD appoints Angelique Kruif as Global People Director
People | April 23, 2026

IMCD appoints Angelique Kruif as Global People Director

Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations


New brain study reveals why alcohol relapse remains a persistent challenge
R&D | April 22, 2026

New brain study reveals why alcohol relapse remains a persistent challenge

These findings help explain how relapse-triggering memories can persist alongside those that support recovery


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


Ultomiris shows strong interim results in Phase III IgA nephropathy trial
Clinical Trials | April 22, 2026

Ultomiris shows strong interim results in Phase III IgA nephropathy trial

IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys


BioMed X launches AI-driven bispecific antibody research team in France
Biotech | April 21, 2026

BioMed X launches AI-driven bispecific antibody research team in France

The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation


NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
R&D | April 21, 2026

NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine

The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways